secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001420720-22-000096
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio closes $3.5M underwritten public offering of common stock and warrants
---------------------------------------------------------------------------

- Offering includes 3,365,385 shares (or pre-funded warrants) plus Series A and B warrants at $1.04 per share.
- Series A warrants expire 5 years; Series B warrants expire 24 months from issuance, both immediately exercisable.
- Gross proceeds ~$3.5M; net proceeds for operating costs, R&D, working capital, and debt payments.
- Underwriter H.C. Wainwright partially exercised option for additional warrants to buy up to 1,009,614 shares.
- Shareholder votes at Dec 8 annual meeting: elected directors Armstrong and Kropotova, ratified auditor, approved say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/ibio-20221208x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-22-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer